AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology o... ( distribution publishing andevents. The ...)

AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine

Date:11/11/2008

, distribution, publishing and events. The Nobel Program portfolio comprises a number of documentaries and TV-productions: The Nobel Prize Award Ceremonies in Stockholm and Oslo, The Nobel Banquet, Nobel Documentaries, Nobel Minds, Nobel Highlights and the Nobel Prize Concert. These programs are distributed in Sweden and internationally and reach a large audience.

About Nobel Web AB

Nobel Web AB is responsible for Nobelprize.org, the official website of the Nobel Foundation. Nobelprize.org acts as the online gateway to the Nobel Foundation's activities and hosts a unique collection of archival material on all Nobel Prizes from their inception in 1901 to the present day. Currently receiving well over 35 million visitors a year, Nobelprize.org aims to be the best source of information and educational materials related to the Nobel Prizes, and the site offers audio and video interviews, articles and interactive games alongside coverage of Nobel Prize Announcements and the Award Ceremonies. Building on this deep base of resources focused around every individual Nobel Prize, Nobelprize.org aims to offer extra levels of understanding, affording visitors a larger view of the history of science and exhibiting each Prize within its broader context.

Nobel Media(R), Nobelprize.org(R) and Nobel Prize(R) are registered trademarks of the Nobel Foundation.

Media Contacts:

AstraZeneca

Neil McCrae/Chris Sampson (London), +44-207-304-5045/5130

Alex Kalombaris, Head of Global R&D Communication, Tel: +44-207-304-5027

Anne-Charlotte Knutsson (Sodertalje, Sweden), +46(8)553-213-75

Nobel Media and Nobel Web

Merci Olsson

Marketing and Communications Manager

Tel: +46-738-52-35-95

E-mail: merci.olsson@nobel.se

0

GOOD

Page: 1 2 3
Related biology technology :

1. Pediatric Asthma Programs Featuring PARI Pharmas eFlow Acquired by AstraZeneca
2. AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune
3. AstraZeneca and Banner Alzheimers Institute Collaborate to Evaluate New Tool Targeting Alzheimers Disease
4. Epistem plc and AstraZeneca Complete Plucked Hair Biomarker Study for Oncology Drug Development
5. Meditrina Pharmaceuticals, Inc. Announces Exclusive Global License Agreement With AstraZeneca
6. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
7. AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
8. AstraZeneca Completes Enrollment in Two Pivotal Phase III Studies of the Investigational Drug Vandetanib (ZACTIMA(R)) in Non-Small Cell Lung Cancer (NSCLC)
9. Silence Therapeutics and AstraZeneca Announce Collaboration to Develop Novel Approaches for siRNA Drug Delivery
10. AstraZenecas Zactima to Earn Almost Five Percent Patient Share in the Treatment of Non-Small-Cell Lung Cancer by 2016
11. Ranbaxy and AstraZeneca Reach Agreement in Esomeprazole Patent Litigation

Post Your Comments:

AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology o...( distribution publishing andevents. The ...)